ALK and neoplasm: Although multivariate analysis could not be performed due to the small sample size of crizotinib-treated patients, we did demonstrate by univariate analysis that tumor with moderate and strong ALK expression marginally predicted improved OS2 and significantly predicted a decreased risk of death.